Opto Circuits (India) is currently trading at Rs. 154.60, up by 0.20 points or 0.13% from its previous closing of Rs. 154.40 on the BSE.
The scrip opened at Rs. 155.70 and has touched a high and low of Rs. 156.60 and Rs. 153.05 respectively. So far 45503 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 233.08 on 01-Jul-2011 and a 52 week low of Rs. 141.00 on 20-Dec-2011.
Last one week high and low of the scrip stood at Rs. 157.00 and Rs. 151.00 respectively. The current market cap of the company is Rs. 3736.57 crore.
The promoters holding in the company stood at 28.12% while Institutions and Non-Institutions held 38.71% and 33.16% respectively.
Opto Circuits (India)’s subsidiary and global leader in automated external defibrillators (AED), Cardiac Science Corporation, has launched its CE-certified Powerheart G5, the next-generation AED to help save lives from sudden cardiac arrest (SCA) in Europe.
The Powerheart G5, which enters a global AED market valued at $550 million as of 2011, is design to enable both professional rescuers and first-time users to swiftly provide effective, life-saving therapy to aid a person who has suffered SCA. It the first AED to combine real-time CPR guidance for the rescuer, customized patient therapy, and fast shock times, providing significant differentiator and greatly expanded features vis-à-vis competition.
Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 534.85 |
| Poly Medicure | 1468.25 |
| Laxmi Denta | 195.10 |
| Nureca Ltd. | 263.80 |
| Hemant Surgical Inds | 297.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: